BSE filing, NSE: KIMS. Summary written from the filing by ALFA Finder's alert engine.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹705.00
- Market cap
- ₹29,610 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 144.9×Sector 51.1×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Legal & Regulatory
KIMS discloses a pending suit over its Chennai hospital land lease, naming it defendant. Supreme Court dismissed its SLP; no injunction halts the project.
Krishna Institute of Medical Sciences Other Announcement
The company filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Krishna Institute of Medical Sciences Other Announcement
KIMS provided additional information regarding the board meeting held on October 06, 2026, in response to a BSE query.
Krishna Institute of Medical Sciences Acquisition Worth ₹75 Cr
KIMS will acquire a 51% stake in Insignia Healthcare Private Limited for ₹75 Crore as a strategic investment. This will occur in tranches over 24 months.
- Value
- ₹75.00 Cr
- Execution
- 12 to 24 Months
Krishna Institute of Medical Sciences Acquisition Worth ₹40 Cr
KIMS will acquire a 22% equity stake in Splendid Hospitals Private Limited for up to ₹40 Crore. This strategic investment will be executed via primary infusion.
- Value
- ₹40.00 Cr
- Execution
- On or before 31.03.2027
Krishna Institute of Medical Sciences Acquisition Worth ₹80 Cr
KIMS will acquire a 51% stake in Sarvottam Health Care Private Limited for up to ₹80.00 Crore.
- Value
- ₹80.00 Cr
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.